305 related articles for article (PubMed ID: 2288441)
1. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
Guglielmone HA; Vides MA
Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
[TBL] [Abstract][Full Text] [Related]
2. [Prothrombin time and its standardization].
Kagawa K
Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
[TBL] [Abstract][Full Text] [Related]
3. [Variability of INR due to thromboplastin. Comparison of two recombinant thromboplastins and one rabbit thromboplastin].
Renier JL; Baufine-Ducrocq H; Samama MM
Ann Biol Clin (Paris); 1995; 53(6):353-6. PubMed ID: 8572381
[TBL] [Abstract][Full Text] [Related]
4. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
Gouin I; Horellou MH; Conard J; Samama M
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
[TBL] [Abstract][Full Text] [Related]
5. [Quality control of ISI/INR system in oral anticoagulant therapy].
Kazama M
Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination].
Lämmle B; Furlan M; Sulzer I
Schweiz Med Wochenschr; 1989 Feb; 119(6):178-83. PubMed ID: 2928740
[TBL] [Abstract][Full Text] [Related]
7. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
Loeliger EA; van den Besselaar AM; Lewis SM
Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
[TBL] [Abstract][Full Text] [Related]
8. Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
Tripodi A; Chantarangkul V; Braga M; Poller L; ten Cate JW; van den Besselaar AM; Mannucci PM
Thromb Haemost; 1994 Aug; 72(2):261-7. PubMed ID: 7831663
[TBL] [Abstract][Full Text] [Related]
9. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
10. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
Kitchen S; Preston FE
Semin Thromb Hemost; 1999; 25(1):17-25. PubMed ID: 10327216
[TBL] [Abstract][Full Text] [Related]
11. [Control of the treatment with oral anticoagulants and prothrombin time].
Marzouka E
Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
[TBL] [Abstract][Full Text] [Related]
12. [Obtaining a reference pattern of rabbit brain thromboplastin].
Martínez Placencia BM; Lanzetti Theiler MC; Córdova Caballero MS
Rev Invest Clin; 1989; 41(3):247-52. PubMed ID: 2813999
[TBL] [Abstract][Full Text] [Related]
13. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
[TBL] [Abstract][Full Text] [Related]
14. [Control of oral anticoagulation. Current concepts].
Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.
Kazama M; Suzuki S; Abe T; Tahara C; Shimazu C; Akiyama Y; Higashi K; Ishiguro I; Kimura T; Motoi S
Thromb Haemost; 1990 Dec; 64(4):535-41. PubMed ID: 2084938
[TBL] [Abstract][Full Text] [Related]
16. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
17. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
van den Besselaar AM
J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
[TBL] [Abstract][Full Text] [Related]
18. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.
van den Besselaar AM
Thromb Haemost; 2000 Sep; 84(3):410-2. PubMed ID: 11019963
[TBL] [Abstract][Full Text] [Related]
19. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
20. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
Horsti J
Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
